ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples鈥攕erum, plasma, cell culture supernatants and cell lysates鈥攊ndicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
The global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing was estimated to be worth US$ 179 million in 2023 and is forecast to a readjusted size of US$ 230.5 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing by region & country, by Type, and by Application.
The Enzyme-Linked Immunosorbent Assay (Elisa) Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (Elisa) Testing.
Market Segmentation
By Company
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific. Inc.
Life Technologies Corporation
ZEUS Scientific, Inc.
R & D Systems (a Biotechne brand)
Abbexa
Abcam
Abelisa
Abnova
Bhat Bio-tech
Bio-Rad Laboratories
Biorbyt
Calbiotech
Cayman Chemicals
Crystal Chem
Diagenics
Eagle Biosciences
Segment by Type:
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Competitive ELISA
Segment by Application
Immunology
Inflammation
Infectious diseases
Cancer
Protein quantitation
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Introduction
1.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size Forecast
1.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Trends & Drivers
1.3.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industry Trends
1.3.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Drivers & Opportunity
1.3.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Challenges
1.3.4 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Players Revenue Ranking (2023)
2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue by Company (2019-2024)
2.3 Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (Elisa) Testing
2.6 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Competitive Analysis
2.6.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sandwich ELISA
3.1.2 Indirect ELISA
3.1.3 Multiple and portable ELISA
3.1.4 Competitive ELISA
3.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type
3.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Type (2019-2030)
3.2.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunology
4.1.2 Inflammation
4.1.3 Infectious diseases
4.1.4 Cancer
4.1.5 Protein quantitation
4.1.6 Other
4.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application
4.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Application (2019-2030)
4.2.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region
5.1.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2019-2024)
5.1.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2025-2030)
5.1.4 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
5.2.2 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
5.3.2 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
5.5.2 South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value
6.3 United States
6.3.1 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.3.2 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.4.2 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.5.2 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.6.2 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.7.2 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030
6.9.2 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ortho-Clinical Diagnostics, Inc.
7.1.1 Ortho-Clinical Diagnostics, Inc. Profile
7.1.2 Ortho-Clinical Diagnostics, Inc. Main Business
7.1.3 Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.1.4 Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Ortho-Clinical Diagnostics, Inc. Recent Developments
7.2 Thermo Fisher Scientific. Inc.
7.2.1 Thermo Fisher Scientific. Inc. Profile
7.2.2 Thermo Fisher Scientific. Inc. Main Business
7.2.3 Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.2.4 Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific. Inc. Recent Developments
7.3 Life Technologies Corporation
7.3.1 Life Technologies Corporation Profile
7.3.2 Life Technologies Corporation Main Business
7.3.3 Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.3.4 Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.3.5 ZEUS Scientific, Inc. Recent Developments
7.4 ZEUS Scientific, Inc.
7.4.1 ZEUS Scientific, Inc. Profile
7.4.2 ZEUS Scientific, Inc. Main Business
7.4.3 ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.4.4 ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.4.5 ZEUS Scientific, Inc. Recent Developments
7.5 R & D Systems (a Biotechne brand)
7.5.1 R & D Systems (a Biotechne brand) Profile
7.5.2 R & D Systems (a Biotechne brand) Main Business
7.5.3 R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.5.4 R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.5.5 R & D Systems (a Biotechne brand) Recent Developments
7.6 Abbexa
7.6.1 Abbexa Profile
7.6.2 Abbexa Main Business
7.6.3 Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.6.4 Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Abbexa Recent Developments
7.7 Abcam
7.7.1 Abcam Profile
7.7.2 Abcam Main Business
7.7.3 Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.7.4 Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Abcam Recent Developments
7.8 Abelisa
7.8.1 Abelisa Profile
7.8.2 Abelisa Main Business
7.8.3 Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.8.4 Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Abelisa Recent Developments
7.9 Abnova
7.9.1 Abnova Profile
7.9.2 Abnova Main Business
7.9.3 Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.9.4 Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Abnova Recent Developments
7.10 Bhat Bio-tech
7.10.1 Bhat Bio-tech Profile
7.10.2 Bhat Bio-tech Main Business
7.10.3 Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.10.4 Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bhat Bio-tech Recent Developments
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Profile
7.11.2 Bio-Rad Laboratories Main Business
7.11.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.11.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Bio-Rad Laboratories Recent Developments
7.12 Biorbyt
7.12.1 Biorbyt Profile
7.12.2 Biorbyt Main Business
7.12.3 Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.12.4 Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Biorbyt Recent Developments
7.13 Calbiotech
7.13.1 Calbiotech Profile
7.13.2 Calbiotech Main Business
7.13.3 Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.13.4 Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Calbiotech Recent Developments
7.14 Cayman Chemicals
7.14.1 Cayman Chemicals Profile
7.14.2 Cayman Chemicals Main Business
7.14.3 Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.14.4 Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.14.5 Cayman Chemicals Recent Developments
7.15 Crystal Chem
7.15.1 Crystal Chem Profile
7.15.2 Crystal Chem Main Business
7.15.3 Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.15.4 Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Crystal Chem Recent Developments
7.16 Diagenics
7.16.1 Diagenics Profile
7.16.2 Diagenics Main Business
7.16.3 Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.16.4 Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Diagenics Recent Developments
7.17 Eagle Biosciences
7.17.1 Eagle Biosciences Profile
7.17.2 Eagle Biosciences Main Business
7.17.3 Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions
7.17.4 Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Eagle Biosciences Recent Developments
8 Industry Chain Analysis
8.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industrial Chain
8.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Model
8.5.2 Sales Channel
8.5.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific. Inc.
Life Technologies Corporation
ZEUS Scientific, Inc.
R & D Systems (a Biotechne brand)
Abbexa
Abcam
Abelisa
Abnova
Bhat Bio-tech
Bio-Rad Laboratories
Biorbyt
Calbiotech
Cayman Chemicals
Crystal Chem
Diagenics
Eagle Biosciences
听
听
*If Applicable.
